Curie Cancer : the launch of biotechnology company Honing Biosciences

<p> Institut Curie (<a href="/en/carnot-institute/curie-cancer" target="_blank">Curie Cancer Carnot Institute</a>) announces the launch of biotechnology company Honing Biosciences, a technology platform that develops solutions to optimize the efficiency and safety of cell therapies in cancer and chronic diseases.</p> <p class="text-align-justify"> Cell-based therapy modify and use the cells to restore the function of a tissue or organ or to cure a disease. The goal is to provide long-term care for cancer patients through a single injection of therapeutic cells.</p> <p class="text-align-justify"> Honing Biosciences relies on proprietary technologies that enable precise control of cellular functions, providing a unique answer to current limitations.</p> <p class="text-align-justify"> <a class="lien" href="https://techtransfer.institut-curie.org/news/innovation/institut-curie-…; target="_blank">More details</a></p>